ChemoMetec A/S updated earnings guidance for the fiscal year 2022/2023. For the year, the company expected revenue of DKK 430 million - DKK 460 million, against the previous guidance of DKK 485 million-DKK 505 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
372.1 DKK | +0.68% |
|
+6.70% | -3.09% |
Jul. 02 | ChemoMetec A/S Announces Preliminary Revenue for the Fourth Quarter and Full Year of 2024 | CI |
May. 27 | Denmark's ChemoMetec Appoints New CFO | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.09% | 932M | |
+75.69% | 12.57B | |
-29.24% | 6.9B | |
-8.77% | 5.69B | |
+5.81% | 5.04B | |
-17.19% | 4.69B | |
+17.07% | 4.18B | |
-18.25% | 3.86B | |
-21.23% | 2.97B | |
-0.87% | 1.99B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023